Theralase Technologies Inc. (CVE:TLT – Get Free Report)’s stock price shot up 3.7% during trading on Friday . The company traded as high as C$0.28 and last traded at C$0.28. 108,776 shares changed hands during mid-day trading, a decline of 50% from the average session volume of 217,092 shares. The stock had previously closed at C$0.27.
Theralase Technologies Trading Up 1.9%
The company’s fifty day moving average price is C$0.26 and its two-hundred day moving average price is C$0.21. The company has a quick ratio of 3.40, a current ratio of 0.83 and a debt-to-equity ratio of 29.26. The company has a market cap of C$71.53 million, a price-to-earnings ratio of -15.00 and a beta of -0.29.
About Theralase Technologies
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Read More
- Five stocks we like better than Theralase Technologies
- “I just bought 10,000 shares of a $5 stock…”
- 3 Signs You May Want to Switch Financial Advisors
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Central banks just did something they haven’t done since 1967
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
